Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice

Phytomedicine

Volumn 17, Issue 6, 2010, Pages 397-403

  Ibarra, Alvin ^a   Feuillere, Nicolas ^b   Roller, Marc ^b   Lesburgere, Edith ^c   Beracochea, Daniel ^c  

^a Naturex Inc   (United States)

^b Givaudan SA   (Switzerland)

^c UMR 5287   (France)

Author keywords

Anxiety; Exploratory activity; GABA; Melissa officinalis L.; Mice

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRIC ACID; CYRACOS; MELISSA OFFICINALIS EXTRACT; OLEANOLIC ACID; ROSMARINIC ACID; UNCLASSIFIED DRUG; URSOLIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANXIOLYTIC AGENT; CINNAMIC ACID DERIVATIVE; DEPSIDE; PLANT EXTRACT; TRITERPENE;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN; CHRONIC DRUG ADMINISTRATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; EXPLORATORY BEHAVIOR; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS; TRANQUILIZING ACTIVITY; ANIMAL; ANIMAL BEHAVIOR; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; DRUG ADMINISTRATION; DRUG EFFECTS; DRUG THERAPY; MELISSA OFFICINALIS; PHYTOTHERAPY; PLANT;

MELISSA OFFICINALIS; MUS;

4-AMINOBUTYRATE TRANSAMINASE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CINNAMATES; CIRCADIAN RHYTHM; DEPSIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EXPLORATORY BEHAVIOR; GABA AGONISTS; MAZE LEARNING; MELISSA; MICE; MICE, INBRED C57BL; OLEANOLIC ACID; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; TRITERPENES;

EID: 77950022955     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.01.012     Document Type: Article

References (22)

1. Awad R., Levac D., Cybulska P., Merali Z., Trudeau V.L., and Arnason J.T. Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system. Can. J. Physiol. Pharmacol. 85 (2007) 933-942
2. Awad R., Muhammad A., Durst T., Trudeau V.L., and Arnason J.T. Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother. Res. 23 (2009) 1075-1081
3. Beracochea D., and Krazem A. Effects of mamillary body and mediodorsal thalamic lesions on elevated plus maze exploration. Neuroreport 2 (1991) 793-796
4. Beracochea D. Anterograde and retrograde effects of benzodiazepines on memory. ScientificWorldJournal 16 (2006) 1460-1465
5. Calogero A.E., Gallucci W.T., Chrousos G.P., and Gold P.W. Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin-releasing hormone secretion in vitro. Brain Res. 463 (1988) 28-36
6. Carnat A.P., Carnat A., Fraisse D., and Lamaison J.L. The aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. subsp. officinalis) tea. Pharm. Acta Helv. 72 (1998) 301-305
7. Domschke K., and Zwanzger P. GABAergic and endocannabinoid dysfunction in anxiety - future therapeutic targets?. Curr. Pharm. Des. 14 (2008) 3508-3517
8. Herman J.P., Mueller N.K., and Figueiredo H. Role of GABA and gluatamate circuitry in hypothalamo-pituitary-adrenocortical stress intergration. Ann. N. Y. Acad. Sci. 1018 (2004) 35-45
9. Kennedy D.O., Little W., and Scholey A.B. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom. Med. 66 (2004) 607-613
10. Kennedy D.O., Wake G., Savelev S., Tildesley N.T., Perry E.K., Wesnes K.A., and Scholey A.B. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 28 (2003) 1871-1881
11. Krazem A., Borde N., and Beracochea D. Effects of diazepam and beta-ccm on working memory in mice: relationships with emotional recativity. Pharmacol. Biochem. Behav. 68 (2001) 235-244
12. Lalonde, R., Strazielle, C., 2009. Relations between open-field, elevated plus maze, and emergence tests in C57BL/6 and BALB/c mice injected with GABA-and 5HT-anxiolytic agents. Fundam. Clin. Pharmacol. SEpt. Epub ahead of print.
13. Lewis D.A., Cho R.Y., Carter C.S., Eklund K., Forster S., Kelly M.A., and Montrose D. Subunit selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am. J. Psychiatr. 165 (2008) 1585-1593
14. Menzies L., Ooi C., Kamath S., Suckling J., Mc Kenna P., Fletcher P., Bullmore E., and Stephenson C. Effects of gamma-aminobutyric acid modulating drugs on working memory and brain fucntion in patients with schizophrenia. Arch. Gen. Psychiatry 64 (2007) 156-167
15. Method 993.14 AOAC, 2005. Official Methods of Analysis, 18th Edition. AOAC International, Gaithersburg, MD.
16. Parihar M.S., and Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11 (2004) 456-467
17. Pellow S., and File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24 (1986) 525-529
18. Radley J.J., Gosselin K.L., and Sawchenko P.E. A discrete GABAergic-relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci. 29 (2009) 7330-7340
19. Reich E., and Schibli A., 2007. In: High-Performance Thin-Layer Chromatography for the Analysis of Medicinal Plants.
20. Thoeringer C., erhardt A., Sillaber I., Mueller M., Ohl F., Holsboer F., and Keck M. Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6mice. J. Psychopharmacol. (2009) 3 Epub ahead of print
21. USP-31-NF26 S1, 2008. Test for Pesticides - General Chapters: <561> Articles of Botanical Origin. USP, Rockville, MD.
22. Zhang S., and Cranney J. The role off GABA and anxiety in the reconsolidation, of conditioned fear. Behav. Neurosci. 122 (2008) 1295-1305